Cargando…
Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia
Autores principales: | Adikari, Dona H., Kushwaha, Virag V., Jepson, Nigel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328569/ https://www.ncbi.nlm.nih.gov/pubmed/32653299 http://dx.doi.org/10.1016/j.hlc.2020.06.008 |
Ejemplares similares
-
Cardiovascular Collateral Damages at the Time of COVID-19
por: Jacques, Frédéric, et al.
Publicado: (2020) -
Collateral cardiovascular damage during the COVID-19 pandemic
por: Nadarajah, Ramesh, et al.
Publicado: (2021) -
Valve-in-Ring Transcatheter Heart Valve for Severe Tricuspid Regurgitation
por: Cummins, Leigh A., et al.
Publicado: (2019) -
COVID-19-induced collateral damage
Publicado: (2020) -
Cerebro-/Cardiovascular Collateral Damage During the COVID-19 Pandemic: Fact or Fiction?
por: Katsouras, Christos S, et al.
Publicado: (2023)